SCHEMBL1802857

SCHEMBL1802857

Nc1ccnn1-c1nc2ccccc2n1CC(=O)c1ccc(Cl)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CXCR3 P49682 4/20 0.57
▸ CTSD P07339 3/20 0.56
▸ GUSB P08236 2/20 0.56
▸ NOD1 Q9Y239 1/20 0.55
▸ NPSR1 Q6W5P4 2/20 0.53
▸ USP2 O75604 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ ALDH1A1 P00352 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ NPC1 O15118 1/20 0.47
▸ MGAM O43451 1/20 0.47
▸ AMY1A P0DUB6 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ SI P14410 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ MGAM2 Q2M2H8 1/20 0.47
▸ IDO1 P14902 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1801571 0.88 CTSD (0.45) CXCR3CTSDGUSBNOD1NPSR1
SCHEMBL1803118 0.86 MAPT (0.59) CTSDNPSR1TSHRALDH1A1LMNA
SCHEMBL1802569 0.84 SMN1; SMN2 (0.50) CXCR3CTSDGUSBNPSR1ALDH1A1
SCHEMBL1802357 0.81 F2R (0.41) CXCR3CTSDGUSBNPSR1TSHR
SCHEMBL1800064 0.81 CTSD (0.46) CXCR3CTSDNPSR1TSHRALDH1A1
SCHEMBL4996791 0.78 CXCR3 (0.57) CXCR3CTSDGUSBNOD1NPSR1
SCHEMBL1385523 0.73 KDM4E (0.71) CTSDGUSBTSHRALDH1A1LMNA
SCHEMBL1801438 0.69 SMN1; SMN2 (0.49) CXCR3CTSDNPSR1ALDH1A1LMNA
SCHEMBL14470429 0.69 F2R (0.61) CXCR3CTSDGUSBNOD1NPSR1
SCHEMBL5037413 0.68 KDM4E (0.62) TSHRALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951957-B2 Substituted benzimidazoles and their use for inducing apoptosis BASILEA PHARMACEUTICA AG (CH) 2011-05-31 — — US claimed
Send feedback